Clinical Trial Update: Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma

View source ↗

Summary

This clinical trial aims to change paradigms in the prognostic assessment of classical Hodgkin lymphoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma
• Classical Hodgkin Lymphoma Recurrent
• Classical Hodgkin Lymphoma Refractory

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent | Status: RECRUITING